Efficacy between high and medium doses of glucocorticoid therapy in remission induction of IgG4-related diseases: a preliminary randomized controlled trial.

Qingjun WuJie ChangHua ChenYu ChenHongxian YangYunyun FeiPanpan ZhangXiaofeng ZengFengchun ZhangWen Zhang

Published in: International journal of rheumatic diseases (2017)

The effect of remission induction was similar in high and medium glucocorticoid groups. However, patients with more organs involved and higher IgG4-RD RI score at baseline might get more benefit with high dose glucocorticoid for remission induction.

Keyphrases

randomized controlled trial
high dose
disease activity
ulcerative colitis
study protocol
low dose
systemic lupus erythematosus
rheumatoid arthritis